𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin

✍ Scribed by Xiantao Wang; Sudha Govind; Shyama P. Sajankila; Lixin Mi; Rabindra Roy; Fung-Lung Chung


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
380 KB
Volume
55
Category
Article
ISSN
1613-4125

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Scope: Naturally‐occurring chemopreventive agent phenethyl isothiocyanate (PEITC), derived primarily from watercress, has been shown to inhibit cell growth and induce apoptosis in cancer cells. In this study, we examined the potential of PEITC in enhancing cisplatin‐induced apoptosis in cervical cancer cells and its mechanisms.

Methods and results: HeLa cells were exposed to PEITC, cisplatin or both. Pretreatment of cells with PEITC strongly enhanced cisplatin‐induced cytotoxicity. PEITC activated the mitogen‐activated protein kinases, including c‐Jun N‐terminal kinase (JNK), extracellular signal‐related kinase (ERK), and p38. Caspase‐3 activity assay demonstrated that the synergistic induction of apoptosis was significantly attenuated by MEK1/2 inhibitor U0126, but not by JNK or p38 inhibitor, suggesting that ERK activation is responsible for the synergistic effect. We found that NF‐κB signaling pathway is not involved in the synergistic effect. Sulforaphane and benzyl isothiocyanate, two other members of the isothiocyanate family, also sensitize HeLa cells to apoptosis induced by cisplatin. Furthermore, we found that the synergistic effect was also observed in cervical cancer C33A and breast cancer MCF‐7 cells but not in normal mammary epithelial MCF‐10A cells. Finally, we demonstrated that Noxa induction was associated with apoptosis induced by PEITC plus cisplatin.

Conclusion: Taken together, this study shows that PEITC can sensitize cancer cells to apoptosis induced by cisplatin and this effect is mediated through ERK activation, suggesting the potential of PEITC to be used as an adjuvant with cisplatin in combination therapeutic treatments.


📜 SIMILAR VOLUMES


Proteasome inhibitor MG132 sensitizes HP
✍ Brigitte M.T. Hougardy; John H. Maduro; Ate G.J. van der Zee; Derk Jan A. de Gro 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 506 KB

## Abstract In cervical carcinogenesis, the p53 tumor suppressor pathway is disrupted by HPV (human papilloma virus) E6 oncogene expression. E6 targets p53 for rapid proteasome‐mediated degradation. We therefore investigated whether proteasome inhibition by MG132 could restore wild‐type p53 levels

Role of mitogen-activated protein kinase
✍ Dong Xiao; Sunga Choi; Yong J. Lee; Shivendra V. Singh 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

## Abstract The present study was undertaken to examine the role of mitogen‐activated protein kinases (MAPKs) in apoptosis induction by phenethyl isothiocyanate (PEITC), a cruciferous vegetable‐derived cancer chemopreventive agent, with DU145 and LNCaP human prostate cancer cells as a model. The MA

Overexpression of bax sensitizes human b
✍ Chouhei Sakakura; Elizabeth A. Sweeney; Tsutomu Shirahama; Yasuyuki Igarashi; Se 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 553 KB

Resistance to apoptosis plays an important role in tumors that are refractory to chemotherapy and ionizing radiation (IR). bax, which forms a heterddimer with bcl-2 and accelerates apoptosir, is not, or only weakly. expremed in most human breast cancer cells, and weak bax expression is considered to